Drug: NORVIR Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 12 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125546641 | NORVIR | Hepatocellular injury | ABBVIE | 61.24 YR | F | 0 | 20160713 | FR |
| 125581911 | NORVIR | Hepatocellular injury | GLAXOSMITHKLINE | 58.00 YR | M | 63 KG | 20160714 | FR |
| 125612861 | NORVIR | Hepatocellular injury | VIIV | 58.00 YR | M | 63 KG | 20160715 | FR |
| 125664901 | NORVIR | Hepatocellular injury | UCB | 58.00 YR | M | 63 KG | 20160718 | FR |
| 125682681 | NORVIR | Hepatocellular injury | ABBVIE | 58.00 YR | M | 63 KG | 20160718 | FR |
| 125738821 | NORVIR | Hepatocellular injury | BRISTOL MYERS SQUIBB | 61.24 YR | F | 0 | 20160720 | FR |
| 125791211 | NORVIR | Hepatocellular injury | JANSSEN | 58.00 YR | M | 63 KG | 20160721 | FR |
| 125993871 | NORVIR | Hepatocellular injury | SYMPLMED PHARMACEUTICALS | 0.00 | 0 | 20160727 | FR | |
| 126009421 | NORVIR | Hepatocellular injury | BRISTOL MYERS SQUIBB | 63.99 YR | M | 0 | 20160728 | FR |
| 126522661 | NORVIR | Hepatocellular injury | ABBVIE | 44.88 YR | F | 68 KG | 20160815 | FR |
| 126534041 | NORVIR | Hepatocellular injury | GILEAD | 45.00 YR | F | 68 KG | 20160815 | FR |
| 126634771 | NORVIR | Hepatocellular injury | JANSSEN | 44.88 YR | F | 68 KG | 20160818 | FR |
Total Records: 12 Number of Pages: 1